Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | PAM | P19021 | 2/20 | 0.55 |
| ▸ | CES2 | O00748 | 3/20 | 0.54 |
| ▸ | CES1 | P23141 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.52 |
| ▸ | PPARG | P37231 | 6/20 | 0.52 |
| ▸ | PPARD | Q03181 | 6/20 | 0.52 |
| ▸ | PPARA | Q07869 | 6/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TLR2 | O60603 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | FABP4 | P15090 | 2/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.52 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.52 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27778361 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL28126216 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL27771053 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL27640216 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL2734310 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL329071 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL3980640 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL740818 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL8645409 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL28057936 | 1.00 | DGKA (0.61) | DGKALMNAPAMCES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108641459-A | A kind of putty powder for exterior wall and preparation method thereof | 黄旭东 | 2018-10-12 | — | — | CN | claimed |
| CN-1259424-C | Method for increasing long-chain biatomic acid fermentation production rate | SINOPEC CORP (CN) | 2006-06-14 | — | — | CN | claimed |
| CN-1611608-A | Method for increasing long-chain biatomic acid fermentation production rate | CHINA PETROCHEMICAL CO LTD (CN) | 2005-05-04 | — | — | CN | claimed |
| CN-118159549-A | Immunomodulators | 百时美施贵宝公司 | 2024-06-07 | — | — | CN | disclosed |
| US-20230348362-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2023-11-02 | — | — | US | disclosed |
| WO-2023069994-A1 | IMMUNOMODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-04-27 | — | — | WO | disclosed |
| EP-3443042-A1 | OPTICAL EVANESCENT COLOR CHANGE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | Segan Industries, Inc. (US) | 2019-02-20 | — | — | EP | disclosed |
| CN-108641459-A | A kind of putty powder for exterior wall and preparation method thereof | 黄旭东 | 2018-10-12 | — | — | CN | disclosed |
| WO-2017180898-A1 | OPTICAL EVANESCENT COLOR CHANGE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | SEGAN INDUSTRIES, INC. (US) | 2017-10-19 | — | — | WO | disclosed |
| EP-2969582-A1 | COMPOUNDS FOR REDUCING BACKGROUND COLOR IN COLOR CHANGE COMPOSITIONS | Segan Industries, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014144693-A1 | COMPOUNDS FOR REDUCING BACKGROUND COLOR IN COLOR CHANGE COMPOSITIONS | SEGAN INDUSTRIES, INC. (US) | 2014-09-18 | — | — | WO | disclosed |
| EP-1185692-A1 | MONOLAYER AND ELECTRODE FOR DETECTING A LABEL-BEARING TARGET AND METHOD OF USE THEREOF | The University of North Carolina at Chapel Hill (US) | 2002-03-13 | — | — | EP | disclosed |
| WO-2000065099-A1 | MONOLAYER AND ELECTRODE FOR DETECTING A LABEL-BEARING TARGET AND METHOD OF USE THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2000-11-02 | — | — | WO | disclosed |
| US-6127127-A | Monolayer and electrode for detecting a label-bearing target and method of use thereof | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2000-10-03 | — | — | US | disclosed |
| US-5972630-A | DETERMINING THE PRESENCE OF AN ANALYTE IN SAMPLE; COMPLEXING TWO COMPLEMENTARY SPECIFIC BINDING MEMBERS; THE MEMBERS ARE LIGAND AND RECEPTOR IN SOLUTION, ANALYZING ENZYME ACTIVITY, EVALUATING ACTIVITY BY AMOUNT OF ANALYTE IN SAMPLE | DADE BEHRING MARBURG GMBH (DE) | 1999-10-26 | — | — | US | disclosed |
| US-5919641-A | INCUBATING SAMPLE WITH ENZYME BOUND TO FIRST SPECIFIC BINDING PAIR MEMBER AND ENZYME INHIBITOR BOUND TO SECOND SPECIFIC BINDING PAIR MEMBER, DETECTING ENZYME ACTIVITY WHEN ANALYTE BINDS TO ONE PAIR MEMBER INTERFERING WITH ORIGINAL BINDING | DADE BEHRING MARBURG GMBH (DE) | 1999-07-06 | — | — | US | disclosed |
| EP-0532187-B1 | Homogeneous immunoassays using enzyme inhibitors | BEHRINGWERKE AG (DE) | 1996-10-30 | — | — | EP | disclosed |
| EP-0532187-A1 | Homogeneous immunoassays using enzyme inhibitors | BEHRINGWERKE Aktiengesellschaft (DE) | 1993-03-17 | — | — | EP | disclosed |
| US-5134128-A | Immunosuppressive and antiproliferative activity for psoriasis and calcium homeostasis | ALLERGAN, INC. (US) | 1992-07-28 | — | — | US | disclosed |
| EP-0295056-A1 | Anti-inflammatory furanones | ALLERGAN, INC (US) | 1988-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348362-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | CETP, NPC1, LCAT | DGKA 614/4885LMNA 305/4885PAM 2183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.